Business

Business

Views on running a successful MedTech company.

Senior Director, Simon-Kucher & Partners, Division Life Sciences
The medical technology sector is characterised by innovation. This is true not just of how technologies are developed and manufactured – it extends equally to...
Most of the dialogue on cyber risk focuses on the adversaries and the threats they pose, often highlighting their sophistication, resources, and connections to...
2015 has been predicted, by many commentators, as the year that digital health will officially ‘’take off’’ due to increased consumer-wide acceptance, a...
Chief Executive Officer, MedTech Europe, EDMA & Eucomed
Europe is known for its excellent startup ecosystem. Moreover, the medtech industry in Europe is made up of 95% SMEs. If we want the innovation successes of past and present to continue well into the future, it is critical that the bigger medtech players, and the financial and investment ecosystem keep taking the pulse of European medtech startups.
What you can learn from Coloplast’s perspective-driven approach to innovation. Coloplast, a long established leader in ostomy and continence care, was losing its competitive edge. Despite an endless stream of new products with ever more new features in the pipeline, they kept missing their sales targets. Coloplast found that its traditional market research was only leading them further astray: the research reported that there were thousands of possible problems to solve in ostomy care—some related to the issue of leakage—but it couldn’t offer any insight into which ones mattered the most to users and why. Management knew that they needed to have a clear answer to the company’s most fundamental question: what problems are we trying to solve?